InteGen Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$4.18M
InteGen General Information
Description
Developer of an interphase chromosome profiling tool designed for the cytogenetics community. The company's platform offers multiple-sequential hybridizations and a two-dual filter detection system to achieve comprehensive genome coverage, enabling fertility clinics and IVF doctors with clinical and cost-effective tools to detect balanced and unbalanced sub-telomere rearrangements.
Contact Information
Website
www.integenllc.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Primary Office
- 8865 Commodity Circle
- Suite 2
- Orlando, FL 32819
- United States
+1 (407) 000-0000
InteGen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Seed Round | 23-Oct-2018 | $4.18M | 00.000 | Completed | Startup | |
| 1. Angel (individual) | 24-Jan-2011 | 00000 | 00000 | Completed | Startup |
InteGen Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Ramesh Vallabhaneni | Founder & Chief Executive Officer |
InteGen Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
